Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Danlou Tablet () on peri-procedural myocardial injury among patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndrome: A study protocol of a multicenter, randomized, controlled trial.
Wang L, Mao S, Qi JY, Ren Y, Guo XF, Chen KJ, Zhang MZ. Wang L, et al. Among authors: guo xf. Chin J Integr Med. 2015 Sep;21(9):662-6. doi: 10.1007/s11655-015-2284-1. Epub 2015 Jul 4. Chin J Integr Med. 2015. PMID: 26142341 Clinical Trial.
Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease.
Mao W, Zhang L, Zou C, Li C, Wu Y, Su G, Guo X, Wu Y, Lu F, Lin Q, Wang L, Bao K, Xu P, Zhao D, Peng Y, Liang H, Lu Z, Gao Y, Jie X, Zhang L, Wen Z, Liu X. Mao W, et al. BMC Complement Altern Med. 2015 Sep 8;15:316. doi: 10.1186/s12906-015-0830-1. BMC Complement Altern Med. 2015. PMID: 26351087 Free PMC article. Clinical Trial.
Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial.
Wang L, Zhao X, Mao S, Liu S, Guo X, Guo L, Du T, Yang H, Zhao F, Wu K, Cong H, Wu Y, Yang PC, Chen K, Zhang M. Wang L, et al. Evid Based Complement Alternat Med. 2016;2016:7960503. doi: 10.1155/2016/7960503. Epub 2016 Nov 8. Evid Based Complement Alternat Med. 2016. PMID: 27895696 Free PMC article.
389 results